Literature DB >> 24874956

Proceedings of the Annual Symposium & Plenary Session on Regenerative Medicine (PASRM).

.   

Abstract

Entities:  

Year:  2012        PMID： 24874956      PMCID： PMC3908298     

Source DB:  PubMed          Journal:  J Stem Cells Regen Med        ISSN： 0973-7154


× No keyword cloud information.
  27 in total

1.  Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach.

Authors:  Masahiro Takada; Hiroshi Terunuma; Xuewen Deng; Md Zahidunnabi Dewan; Shigehira Saji; Katsumasa Kuroi; Naoki Yamamoto; Masakazu Toi
Journal:  Breast Cancer       Date:  2010-03-31       Impact factor: 4.239

2.  Cytotoxic T-lymphocyte immunotherapy for ovarian cancer: a pilot study.

Authors:  Stephen E Wright; Kathleen A Rewers-Felkins; Imelda S Quinlin; Catherine A Phillips; Mary Townsend; Ramila Philip; Mark J Dobrzanski; Pamela R Lockwood-Cooke; William Robinson
Journal:  J Immunother       Date:  2012 Feb-Mar       Impact factor: 4.456

3.  Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes.

Authors:  A E Sloan; R Dansey; L Zamorano; G Barger; C Hamm; F Diaz; R Baynes; G Wood
Journal:  Neurosurg Focus       Date:  2000-12-15       Impact factor: 4.047

4.  Synergistic cytotoxicity of ex vivo expanded natural killer cells in combination with monoclonal antibody drugs against cancer cells.

Authors:  Xuewen Deng; Hiroshi Terunuma; Mie Nieda; Weihua Xiao; Andrew Nicol
Journal:  Int Immunopharmacol       Date:  2012-10-09       Impact factor: 4.932

Review 5.  Review: side effects of approved molecular targeted therapies in solid cancers.

Authors:  Christian Widakowich; Gilberto de Castro; Evandro de Azambuja; Phuong Dinh; Ahmad Awada
Journal:  Oncologist       Date:  2007-12

Review 6.  Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.

Authors:  Hiroshi Terunuma; Xuewen Deng; Zahidunnabi Dewan; Shigeyoshi Fujimoto; Naoki Yamamoto
Journal:  Int Rev Immunol       Date:  2008       Impact factor: 5.311

7.  Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck.

Authors:  Francesco Recchia; Giampiero Candeloro; Mario Di Staso; Stefano Necozione; Roberta Bisegna; Massimo Bratta; Vincenzo Tombolini; Silvio Rea
Journal:  J Immunother       Date:  2008-05       Impact factor: 4.456

8.  Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial.

Authors:  Koji Kono; Akihiro Takahashi; Fumiko Ichihara; Hideki Amemiya; Hidehiko Iizuka; Hideki Fujii; Takayoshi Sekikawa; Yoshiro Matsumoto
Journal:  Clin Cancer Res       Date:  2002-06       Impact factor: 12.531

Review 9.  Proton beam therapy.

Authors:  W P Levin; H Kooy; J S Loeffler; T F DeLaney
Journal:  Br J Cancer       Date:  2005-10-17       Impact factor: 7.640

10.  Proceedings of the Annual Symposium on Regenerative Medicine(PASRM).

Authors: 
Journal:  J Stem Cells Regen Med       Date:  2006-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.